Drug Name: 

EVINACUMAB

Drug Description: 
Angptl3 Antibody
Target Condition: 
Homozygous familial hypercholesterolemia, severe forms of hyperlipidemia
Rank: 
30
Phase: 
Phase 2

NOW APPROVED IN THE UNITED STATES